{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:05:40Z","timestamp":1785283540560,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Roche S.p.A"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics Open"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s41669-017-0048-x","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T11:47:12Z","timestamp":1503402432000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders\u2019 Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)"],"prefix":"10.1007","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-4743","authenticated-orcid":false,"given":"Martina","family":"Garau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Amedeo","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Profico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"48_CR1","unstructured":"HTAi Patient and Citizen Involvement. Good Practice Examples of Patient and Public Involvement in Health Technology Assessment. 2015. http:\/\/www.htai.org\/fileadmin\/HTAi_Files\/ISG\/PatientInvolvement\/EffectiveInvolvement\/Good_Practice_Examples_Feb_2015.pdf . Accessed 14 Aug 2017."},{"key":"48_CR2","unstructured":"SMC. PACE\u2014patient and clinician engagement. Factsheet. 2015. https:\/\/www.scottishmedicines.org.uk\/files\/PACE\/PACE_factsheet_0417.pdf . Accessed 14 Aug 2017."},{"issue":"1","key":"48_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S0266462312000669","volume":"29","author":"KK Shah","year":"2013","unstructured":"Shah KK, Mestre-Ferrandiz J, Towse A, Smyth EN. A review of health technology appraisals: case studies in oncology. Int J Technol Assess Health Care. 2013;29(1):101\u20139.","journal-title":"Int J Technol Assess Health Care"},{"key":"48_CR4","volume-title":"Incorporating multiple criteria in HTA: methods and processes. OHE Monograph","author":"N Devlin","year":"2011","unstructured":"Devlin N, Sussex J. Incorporating multiple criteria in HTA: methods and processes. OHE Monograph. London: Office of Health Economics; 2011."},{"issue":"4","key":"48_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S0266462311000523","volume":"27","author":"M Danner","year":"2011","unstructured":"Danner M, Hummel JM, Volz F, van Manen JG, Wiegard B, Dintsios CM, et al. Integrating patients\u2019 views into health technology assessment: analytic hierarchy process (AHP) as a method to elicit patient preferences. Int J Technol Assess Health Care. 2011;27(4):369\u201375.","journal-title":"Int J Technol Assess Health Care"},{"issue":"1","key":"48_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2015.12.003","volume":"19","author":"P Thokala","year":"2016","unstructured":"Thokala P, Devlin N, Marsh K, Baltussen R, Boysen M, Kalo Z, et al. Multiple criteria decision analysis for health care decision making-an introduction: report 1 of the ISPOR MCDA emerging good practices task force. Value Health. 2016;19(1):1\u201313.","journal-title":"Value Health."},{"issue":"1","key":"48_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0266462313000639","volume":"30","author":"G Radaelli","year":"2014","unstructured":"Radaelli G, Lettieri E, Masella C, Merlino L, Strada A, Tringali M. Implementation of EUnetHTA core Model(R) in Lombardia: the VTS framework. Int J Technol Assess Health Care. 2014;30(1):105\u201312.","journal-title":"Int J Technol Assess Health Care"},{"key":"48_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-319-47540-0_8","volume-title":"Multi-criteria decision analysis to support healthcare decisions","author":"H Castro","year":"2017","unstructured":"Castro H, Tringali M, Cleemput I, Devriese S, Leoni O, Lettieri E. Advancing MCDA and HTA into coverage decision-making. In: Marsh K, Goetghebeur M, Thokala P, Baltussen R, editors. Multi-criteria decision analysis to support healthcare decisions. Cham: Springer International Publishing; 2017. p. 119\u201346."},{"key":"48_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12961-015-0011-1","volume":"13","author":"P Wahlster","year":"2015","unstructured":"Wahlster P, Goetghebeur M, Schaller S, Kriza C, Kolominsky-Rabas P. Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study. Health Res Policy Syst. 2015;13:24.","journal-title":"Health Res Policy Syst."},{"issue":"2","key":"48_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jval.2016.12.011","volume":"20","author":"TG Bentley","year":"2017","unstructured":"Bentley TG, Cohen JT, Elkin EB, Huynh J, Mukherjea A, Neville TH, et al. Validity and reliability of value assessment frameworks for new cancer drugs. Value Health. 2017;20(2):200\u20135.","journal-title":"Value Health."},{"issue":"3","key":"48_CR11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40273-015-0340-5","volume":"34","author":"M Wagner","year":"2016","unstructured":"Wagner M, Khoury H, Willet J, Rindress D, Goetghebeur M. Can the EVIDEM framework tackle issues raised by evaluating treatments for rare diseases: analysis of issues and policies, and context-specific adaptation. Pharmacoeconomics. 2016;34(3):285\u2013301.","journal-title":"Pharmacoeconomics"},{"key":"48_CR12","doi-asserted-by":"crossref","first-page":"a1850","DOI":"10.1136\/bmj.a1850","volume":"337","author":"N Daniels","year":"2008","unstructured":"Daniels N, Sabin JE. Accountability for reasonableness: an update. BMJ. 2008;337:a1850.","journal-title":"BMJ"},{"key":"48_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1472-6963-11-329","volume":"11","author":"M Tony","year":"2011","unstructured":"Tony M, Wagner M, Khoury H, Rindress D, Papastavros T, Oh P, et al. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res. 2011;11:329.","journal-title":"BMC Health Serv Res."},{"key":"48_CR14","doi-asserted-by":"crossref","unstructured":"Gilabert-Perramon A, Catalan A, Prat A, Fontanet M, Puig-Peir\u00f3 R, Merino-Montero S, et al. Development of a multi-criteria decision analysis (MCDA) framework for health care decision-making in Catalonia (Spain): pilot study focused in orphan drugs. Vienna: ISPOR 19th Annual European Congress; 2016.","DOI":"10.1016\/j.jval.2016.09.039"},{"key":"48_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-7547-12-22","volume":"12","author":"J Til van","year":"2014","unstructured":"van Til J, Groothuis-Oudshoorn C, Lieferink M, Dolan J, Goetghebeur M. Does technique matter: a pilot study exploring weighting techniques for a multi-criteria decision support framework. Cost Eff Resour Alloc. 2014;12:22.","journal-title":"Cost Eff Resour Alloc."},{"issue":"8","key":"48_CR16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1470-2045(16)30097-3","volume":"17","author":"LH Sehn","year":"2016","unstructured":"Sehn LH, Chua N, Mayer J, Dueck G, Trneny M, Bouabdallah K, et al. Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial. Lancet Oncol. 2016;17(8):1081\u201393.","journal-title":"Lancet Oncol."},{"key":"48_CR17","unstructured":"European Medicines Agency. Assessment report Gazyvaro Procedure No. EMEA\/H\/C\/002799\/II\/0007. 2016. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/002799\/WC500211313.pdf . Accessed 14 Aug 2017."},{"issue":"6","key":"48_CR18","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/annonc\/mdq615","volume":"22","author":"L Lee","year":"2011","unstructured":"Lee L, Wang L, Crump M. Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin\u2019s lymphoma: correlation of complete response, time-to-event and overall survival end points. Ann Oncol. 2011;22(6):1392\u2013403.","journal-title":"Ann Oncol"},{"issue":"3","key":"48_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/12460125.1997.10511726","volume":"6","author":"V Belton","year":"1997","unstructured":"Belton V, Pictet J. A framework for group decision using a MCDA model: sharing, aggregating or comparing individual information? J Decis Syst. 1997;6(3):283\u2013303.","journal-title":"J Decis Syst."},{"key":"48_CR20","first-page":"10","volume":"1","author":"K Claxton","year":"2015","unstructured":"Claxton K. Three questions to ask when examining MCDA. Value Outcomes Spotlight. 2015;1:10\u20138.","journal-title":"Value Outcomes Spotlight."},{"issue":"2","key":"48_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","volume":"19","author":"K Marsh","year":"2016","unstructured":"Marsh K, IJmerzan M, Thokala P, Baltussen R, Boysen M, Kalo Z, et al. Multiple criteria decision analysis for health care decision making\u2014emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force. Value Health. 2016;19(2):125\u201337.","journal-title":"Value Health."},{"key":"48_CR22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-47540-0_14","volume-title":"Multi-criteria decision analysis to support healthcare decisions","author":"M Garau","year":"2017","unstructured":"Garau M, Devlin NJ. Using MCDA as a decision aid in health technology appraisal for coverage decisions: opportunities, challenges and unresolved questions. In: Marsh K, Goetghebeur M, Thokala P, Baltussen R, editors. Multi-criteria decision analysis to support healthcare decisions. Cham: Springer International Publishing; 2017. p. 277\u201398."},{"issue":"1","key":"48_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/2045-4015-1-44","volume":"1","author":"O Golan","year":"2012","unstructured":"Golan O, Hansen P. Which health technologies should be funded? A prioritization framework based explicitly on value for money. Isr J Health Policy Res. 2012;1(1):44.","journal-title":"Isr J Health Policy Res."},{"issue":"1","key":"48_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40273-012-0001-x","volume":"31","author":"J Sussex","year":"2013","unstructured":"Sussex J, Towse A, Devlin N. Operationalizing value-based pricing of medicines: a taxonomy of approaches. Pharmacoeconomics. 2013;31(1):1\u201310.","journal-title":"Pharmacoeconomics."},{"issue":"1","key":"48_CR25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1258\/135581907779497567","volume":"12","author":"A Culyer","year":"2007","unstructured":"Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, et al. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Serv Res Policy. 2007;12(1):56\u20138.","journal-title":"J Health Serv Res Policy."},{"issue":"9","key":"48_CR26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.healthpol.2015.07.007","volume":"119","author":"S Karlsberg Schaffer","year":"2015","unstructured":"Karlsberg Schaffer S, Sussex J, Devlin N, Walker A. Local health care expenditure plans and their opportunity costs. Health Policy. 2015;119(9):1237\u201344.","journal-title":"Health Policy"},{"issue":"3","key":"48_CR27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.healthpol.2008.12.010","volume":"91","author":"J Appleby","year":"2009","unstructured":"Appleby J, Devlin N, Parkin D, Buxton M, Chalkidou K. Searching for cost effectiveness thresholds in the NHS. Health Policy. 2009;91(3):239\u201345.","journal-title":"Health Policy"},{"issue":"14","key":"48_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19140","volume":"19","author":"K Claxton","year":"2015","unstructured":"Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess. 2015;19(14):1\u2013503 (v\u2013vi).","journal-title":"Health Technol Assess."},{"key":"48_CR29","unstructured":"Baltussen R. Question is not whether but how to use MCDA. Value Outcomes Spotlight. 2015;1(1):14\u20136."},{"issue":"2","key":"48_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40258-016-0299-1","volume":"15","author":"K Marsh","year":"2017","unstructured":"Marsh K, Caro JJ, Hamed A, Zaiser E. Amplifying each patient\u2019s voice: a systematic review of multi-criteria decision analyses involving patients. Appl Health Econ Health Policy. 2017;15(2):155\u201362.","journal-title":"Appl Health Econ Health Policy."},{"issue":"1","key":"48_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40258-015-0203-4","volume":"14","author":"AC M\u00fchlbacher","year":"2016","unstructured":"M\u00fchlbacher AC, Kaczynski A. Making good decisions in healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA. Appl Health Econ Health Policy. 2016;14(1):29\u201340.","journal-title":"Appl Health Econ Health Policy."},{"key":"48_CR32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-319-47540-0_16","volume-title":"Multi-criteria decision analysis to support healthcare decisions","author":"LD Phillips","year":"2017","unstructured":"Phillips LD. Best Practice for MCDA in Healthcare. In: Marsh K, Goetghebeur M, Thokala P, Baltussen R, editors. Multi-criteria decision analysis to support healthcare decisions. Cham: Springer International Publishing; 2017. p. 311\u201329."},{"issue":"2\u20133","key":"48_CR33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.healthpol.2010.10.012","volume":"102","author":"O Golan","year":"2011","unstructured":"Golan O, Hansen P, Kaplan G, Tal O. Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights? Health Policy. 2011;102(2\u20133):126\u201335.","journal-title":"Health Policy"}],"container-title":["PharmacoEconomics - Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s41669-017-0048-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-017-0048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-017-0048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T13:37:41Z","timestamp":1570023461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s41669-017-0048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["48"],"URL":"https:\/\/doi.org\/10.1007\/s41669-017-0048-x","relation":{},"ISSN":["2509-4262","2509-4254"],"issn-type":[{"value":"2509-4262","type":"print"},{"value":"2509-4254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}